SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ -- JelloX Biotech's debut at Intel® Innovation in September drew the attention of healthcare experts and pharmaceutical brands alike for the Taiwan-based startup's potential to shape the future of...

BOSTON--(BUSINESS WIRE)--PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, today announced that the organization’s recent research will be presented at the Society for Immunotherapy of...

In recent years, artificial intelligence developers have changed the face of medicine with algorithms capable of detecting the earliest signs of cancer. Owkin, meanwhile, is taking a slightly different approach with its own cancer-spotting...

Deep Bio said it signed a partnership with Visiopharm, a Danish pharmaceutical company, to supply DeepDx Prostate, its deep learning-based prostate cancer pathology image analysis software. Under the agreement, Deep Bio will be able to...

Imagene: The research done by Imagene and Sheba Medical Center was recently published in 'Modern Pathology' journal. TEL AVIV, Israel, September 13, 2022 (Newswire.com) - Imagene, an emerging leader in the field of AI-based precision...

(Vista, CA – Sep 4, 2022)  Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today...